Fatal tumor thrombosis due to an inferior vena cava leiomyosarcoma in a patient with antiphospholipid antibody syndrome

Mayo Clinic Proceedings

Volumn 77, Issue 6, 2002, Pages 595-599

  Espiritu, Joseph D ^a   Creer, Michael H ^a   Miklos, Andrew Z ^a   Bajaj, Madhu S ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ANTICOAGULANT AGENT; ATENOLOL; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CYCLOPHOSPHAMIDE; HEPARIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOMODULATING AGENT; LISINOPRIL; METFORMIN; METHYLPREDNISOLONE; PROTEIN C; PROTEIN S; TRAMADOL; TRIAMTERENE; WARFARIN;

ADULT; ANGIOGRAPHY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; INTERNATIONAL STANDARD UNIT; LEIOMYOSARCOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; PHLEBOGRAPHY; PLASMAPHERESIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; TUMOR THROMBUS;

EID: 0036264291     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/77.6.595     Document Type: Article

References (14)

1. Pathogenesis and treatment of the antiphospholipid antibody syndrome
2. 2-glycoprotein I increase the risk of recurrent venous thromboembolism in patients without systemic lupus erythematosus
3. 2-glycoprotein I antibodies in patients with acute venous thromboembolism: Prevalence and association with recurrent thromboembolism
4. Leiomyosarcoma of the inferior vena cava: Analysis and search of world literature on 141 patients and report of three new cases
5. International registry of inferior vena cava leiomyosarcoma: Analysis of a world series of 218 patients
6. Primary venous leiomyosarcoma: A rare but lethal disease
7. Leiomyosarcoma of the pulmonary veins
8. Leiomyosarcoma of the inferior vena cava: Prognosis and comparison with leiomyosarcoma of other anatomic sites
9. Antiplatelet factor 4 - Heparin antibodies in patients with antiphospholipid antibodies
10. Protein C and S response to danacrine in end-stage renal disease
11. Correction of thrombocytopenia with small dose aspirin in the primary antiphospholipid syndrome
12. Correction of thrombocytopenia with dapsone in the primary antiphospholipid syndrome
13. Splenectomy has a limited role in the management of lupus with thrombocytopenia
14. Antiphospholipid antibodies in megakaryocytic thrombocytopenias